TPD & Induced Proximity Summit Leaderboard
  • Friday, July 10, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 422

Author

Pharma Journalist 8922 posts 0 comments

Darren Green, GSK, conference chair invitation to attend AI in Drug Discovery Virtual Conference

Jan 12, 2021
SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 2nd Annual AI in Drug Discovery Conference taking place on 15 and 16h March 2021 as a virtual…
Read More...

GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria…

Jan 11, 2021
GSK and Medicines for Malaria Venture (MMV) announced that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the…
Read More...

Innovations in parenteral delivery, connectivity and regulatory guidance at Pre-filled Syringes East…

Jan 11, 2021
SMi Reports: 8th annual Pre-Filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. Pre-Filled Syringes East Coast 2021 for your chance to network…
Read More...

Post conference Masterclass in EU Distribution: Strategy & Implementation at Parallel Trade…

Jan 11, 2021
SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade As part of the 15th annual Parallel Trade conference. The two-day…
Read More...

Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of…

Jan 11, 2021
Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug…
Read More...

Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in…

Jan 8, 2021
Celularity Inc. and GX Acquisition Corp announced they have entered into a definitive merger agreement pursuant to which GX Acquisition Corp. will combine with Celularity. Upon the…
Read More...

Affinivax Announces $226 Million Series C Financing to Advance its Pipeline of Novel MAPS Vaccines…

Jan 8, 2021
Affinivax, Inc. a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS (Multiple Antigen Presenting System) platform, announced…
Read More...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational…

Jan 8, 2021
Teva Pharmaceuticals Industries Ltd. and MedinCell announced positive results for study TV46000-CNS-30072 (the RISE study – The Risperidone Subcutaneous Extended-Release Study), a Phase…
Read More...

Pfizer Doses First Participant in Phase 3 Study for Duchenne Muscular Dystrophy Investigational Gene…

Jan 8, 2021
Pfizer Inc. announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate…
Read More...

BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND…

Jan 8, 2021
BlueRock Therapeutics, a preclinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, in collaboration with Memorial Sloan Kettering Cancer Center (MSK),…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
  • Cyllene Raises €33m to Advance Neurogenic Bladder DNA Medicine
  • Biocytogen and Whitehawk Partner on Bispecific ADC Development
  • FDA Grants Rare Pediatric Disease Status to Vanda’s CMT2S Therapy

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.